Similar Long-Term Survival in MIS for Ileal NETs

Minimally invasive surgery (MIS) shows comparable long-term survival outcomes to open surgery for ileal neuroendocrine tumors (i-NETs), with no significant difference in overall survival rates at around 99 to 103 months follow-up. MIS is a viable alternative for i-NETs resection, especially in cases without bulky mesenteric masses or concurrent liver resections. The study suggests MIS achieves similar oncological outcomes to open surgery in the long term.